Lead Product(s) : Brivudine
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome
Details : RP101 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dry Eye Syndromes.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 29, 2019
Lead Product(s) : Brivudine
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
